Clinical Trials Browser

NIH × AZD 6244 × Lymphoid × Clear all

NCT03213691 2025-02-05

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Phase 2 Completed

21 enrolled 11 charts

Lymphoma, Non-Hodgkin, Neuroblastoma, Central Nervous System Neoplasms

NCT01278615 2016-02-03

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase 2 Terminated

16 enrolled 9 charts

Lymphoma, Large B-Cell, Diffuse